UNITED STATES
FORM 10-Q
(Mark One)
| x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| For the quarterly period ended September 30, 2003 |
OR
| o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| For the transition period from to |
Commission file number 1-11239
HCA Inc.
|
Delaware
(State or other jurisdiction of incorporation or organization) |
75-2497104 (I.R.S. Employer Identification No.) |
|
|
One Park Plaza Nashville, Tennessee (Address of principal executive offices) |
37203 (Zip Code) |
|
(615) 344-9551
Not Applicable
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES x NO o
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). YES x NO o
Indicate the number of shares outstanding of each of the issuers classes of common stock, as of the latest practicable date.
| Class of Common Stock | Outstanding at October 31, 2003 | |
|
Voting common stock, $.01 par value
|
474,504,100 shares | |
|
Nonvoting common stock, $.01 par value
|
21,000,000 shares |
HCA INC.
FORM 10-Q
| Page of | ||||||
| Form 10-Q | ||||||
|
Part I.
|
Financial Information
|
|||||
|
Item 1.
|
Financial Statements (Unaudited):
|
|||||
|
Condensed Consolidated Income
Statements for the quarters and nine months ended
September 30, 2003 and 2002.
|
3 | |||||
|
Condensed Consolidated Balance Sheets
September 30, 2003 and December 31, 2002.
|
4 | |||||
|
Condensed Consolidated Statements of Cash
Flows for the nine months ended September 30,
2003 and 2002.
|
5 | |||||
|
Notes to Condensed Consolidated Financial
Statements
|
6 | |||||
|
Item 2.
|
Managements Discussion and Analysis of
Financial Condition and Results of Operations
|
18 | ||||
|
Item 3.
|
Quantitative and Qualitative Disclosure of Market
Risk
|
37 | ||||
|
Item 4.
|
Controls and Procedures
|
37 | ||||
|
Part II.
|
Other Information
|
|||||
|
Item 1.
|
Legal Proceedings
|
38 | ||||
|
Item 6.
|
Exhibits and Reports on Form 8-K
|
39 | ||||
| Signatures | 41 | |||||
2
HCA INC.
| Quarter | Nine Months | |||||||||||||||||
| 2003 | 2002 | 2003 | 2002 | |||||||||||||||
|
Revenues
|
$ | 5,471 | $ | 4,929 | $ | 16,211 | $ | 14,705 | ||||||||||
|
Salaries and benefits
|
2,189 | 1,999 | 6,463 | 5,889 | ||||||||||||||
|
Supplies
|
882 | 795 | 2,597 | 2,351 | ||||||||||||||
|
Other operating expenses
|
952 | 859 | 2,731 | 2,491 | ||||||||||||||
|
Provision for doubtful accounts
|
566 | 411 | 1,571 | 1,150 | ||||||||||||||
|
Insurance subsidiary (gains) losses on sales
of investments
|
(1 | ) | (2 | ) | | 2 | ||||||||||||
|
Equity in earnings of affiliates
|
(52 | ) | (50 | ) | (163 | ) | (156 | ) | ||||||||||
|
Depreciation and amortization
|
283 | 253 | 822 | 752 | ||||||||||||||
|
Interest expense
|
127 | 111 | 364 | 340 | ||||||||||||||
|
Gains on sales of facilities
|
(10 | ) | | (85 | ) | | ||||||||||||
|
Impairment of investment securities
|
| 168 | | 168 | ||||||||||||||
|
Impairment of long-lived assets
|
| | 130 | 19 | ||||||||||||||
|
Investigation related costs
|
3 | 16 | 8 | 46 | ||||||||||||||
| 4,939 | 4,560 | 14,438 | 13,052 | |||||||||||||||
|
Income before minority interests and income taxes
|
532 | 369 | 1,773 | 1,653 | ||||||||||||||
|
Minority interests in earnings of consolidated
entities
|
34 | 34 | 120 | 111 | ||||||||||||||
|
Income before income taxes
|
498 | 335 | 1,653 | 1,542 | ||||||||||||||
|
Provision for income taxes
|
192 | 135 | 638 | 607 | ||||||||||||||
|
Net income
|
$ | 306 | $ | 200 | $ | 1,015 | $ | 935 | ||||||||||
|
Per share data:
|
||||||||||||||||||
|
Basic earnings per share
|
$ | 0.62 | $ | 0.39 | $ | 2.01 | $ | 1.83 | ||||||||||
|
Diluted earnings per share
|
$ | 0.61 | $ | 0.38 | $ | 1.98 | $ | 1.78 | ||||||||||
|
Cash dividends per share
|
$ | 0.02 | $ | 0.02 | $ | 0.06 | $ | 0.06 | ||||||||||
|
Shares used in earnings per share calculations
(in thousands):
|
||||||||||||||||||
|
Basic
|
497,424 | 513,986 | 505,095 | 511,881 | ||||||||||||||
|
Diluted
|
505,612 | 527,260 | 514,077 | 525,659 | ||||||||||||||
See accompanying notes.
3
HCA INC.
| September 30, | December 31, | ||||||||
| 2003 | 2002 | ||||||||
| ASSETS | |||||||||
|
Current assets:
|
|||||||||
|
Cash and cash equivalents
|
$ | 182 | $ | 161 | |||||
|
Accounts receivable, less allowance for doubtful
accounts of $2,494 and $2,045
|
2,924 | 2,788 | |||||||
|
Inventories
|
491 | 462 | |||||||
|
Deferred income taxes
|
494 | 568 | |||||||
|
Other
|
720 | 526 | |||||||
| 4,811 | 4,505 | ||||||||
|
Property and equipment, at cost
|
18,167 | 16,800 | |||||||
|
Accumulated depreciation
|
(7,561 | ) | (7,079 | ) | |||||
| 10,606 | 9,721 | ||||||||
|
Investments of insurance subsidiary
|
1,668 | 1,355 | |||||||
|
Investments in and advances to affiliates
|
666 | 679 | |||||||
|
Goodwill
|
2,489 | 1,994 | |||||||
|
Deferred loan costs
|
72 | 67 | |||||||
|
Other
|
334 | 420 | |||||||
| $ | 20,646 | $ | 18,741 | ||||||
| LIABILITIES AND STOCKHOLDERS EQUITY | |||||||||
|
Current liabilities:
|
|||||||||
|
Accounts payable
|
$ | 749 | $ | 809 | |||||
|
Accrued salaries
|
493 | 438 | |||||||
|
Other accrued expenses
|
1,120 | 1,113 | |||||||
|
Government settlement accrual
|
| 933 | |||||||
|
Long-term debt due within one year
|
502 | 446 | |||||||
| 2,864 | 3,739 | ||||||||
|
Long-term debt
|
8,278 | 6,497 | |||||||
|
Professional liability risks
|
1,332 | 1,193 | |||||||
|
Deferred income taxes and other liabilities
|
1,378 | 999 | |||||||
|
Minority interests in equity of consolidated
entities
|
678 | 611 | |||||||
|
Stockholders equity:
|
|||||||||
|
Common stock $.01 par; authorized 1,650,000,000
shares; outstanding 496,643,000 shares in 2003 and 514,176,000
shares in 2002
|
5 | 5 | |||||||
|
Capital in excess of par value
|
| 93 | |||||||
|
Other
|
5 | 6 | |||||||
|
Accumulated other comprehensive income
|
116 | 73 | |||||||
|
Retained earnings
|
5,990 | 5,525 | |||||||
| 6,116 | 5,702 | ||||||||
| $ | 20,646 | $ | 18,741 | ||||||
See accompanying notes.
4
HCA INC.
| 2003 | 2002 | ||||||||||
|
Cash flows from operating activities:
|
|||||||||||
|
Net income
|
$ | 1,015 | $ | 935 | |||||||
|
Adjustments to reconcile net income to net cash
provided by operating activities:
|
|||||||||||
|
Provision for doubtful accounts
|
1,571 | 1,150 | |||||||||
|
Depreciation and amortization
|
822 | 752 | |||||||||
|
Income taxes
|
221 | 46 | |||||||||
|
Gains on sales of facilities
|
(85 | ) | | ||||||||
|
Impairment of investment securities
|
| 168 | |||||||||
|
Impairment of long-lived assets
|
130 | 19 | |||||||||
|
Payment to Federal government
|
(930 | ) | | ||||||||
|
Changes in operating assets and liabilities
|
(1,477 | ) | (1,195 | ) | |||||||
|
Other
|
93 | 89 | |||||||||
|
Net cash provided by operating activities
|
1,360 | 1,964 | |||||||||
|
Cash flows from investing activities:
|
|||||||||||
|
Purchase of property and equipment
|
(1,318 | ) | (1,240 | ) | |||||||
|
Acquisition of hospitals and health care entities
|
(895 | ) | (118 | ) | |||||||
|
Disposition of hospitals and health care entities
|
152 | 77 | |||||||||
|
Change in investments
|
(236 | ) | (65 | ) | |||||||
|
Other
|
(1 | ) | (21 | ) | |||||||
|
Net cash used in investing activities
|
(2,298 | ) | (1,367 | ) | |||||||
|
Cash flows from financing activities:
|
|||||||||||
|
Issuance of long-term debt
|
1,020 | 1,005 | |||||||||
|
Net change in revolving bank credit facility
|
1,065 | (255 | ) | ||||||||
|
Repayment of long-term debt
|
(418 | ) | (790 | ) | |||||||
|
Payment of cash dividends
|
(30 | ) | (30 | ) | |||||||
|
Repurchases of common stock
|
(751 | ) | (682 | ) | |||||||
|
Issuances of common stock
|
86 | 221 | |||||||||
|
Other
|
(13 | ) | (13 | ) | |||||||
|
Net cash provided by (used in) financing
activities
|
959 | (544 | ) | ||||||||
|
Change in cash and cash equivalents
|
21 | 53 | |||||||||
|
Cash and cash equivalents at beginning of period
|
161 | 85 | |||||||||
|
Cash and cash equivalents at end of period
|
$ | 182 | $ | 138 | |||||||
|
Interest payments
|
$ | 319 | $ | 308 | |||||||
|
Income tax payments
|
$ | 417 | $ | 561 | |||||||
See accompanying notes.
5
HCA INC.
| NOTE 1 | INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS |
| Basis of presentation |
HCA Inc. is a holding company whose affiliates own and operate hospitals and related health care entities. The term affiliates includes direct and indirect subsidiaries of HCA Inc. and partnerships and joint ventures in which such subsidiaries are partners. At September 30, 2003, these affiliates owned and operated 183 hospitals, 78 freestanding surgery centers and provided extensive outpatient and ancillary services. Affiliates of HCA Inc. are also partners in 50/50 joint ventures that own and operate seven hospitals and four freestanding surgery centers that are accounted for using the equity method. The Companys facilities are located in 23 states, England and Switzerland. The terms HCA or the Company, as used in this Quarterly Report on Form 10-Q refer to HCA Inc. and its affiliates unless otherwise stated or indicated by context.
The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. The majority of the Companys expenses are cost of revenue items. Costs that could be classified as general and administrative by HCA would include the HCA corporate office costs which were $40 million and $37 million for the quarters ended September 30, 2003 and 2002, respectively, and $113 million and $102 million for the nine months ended September 30, 2003 and 2002, respectively. Operating results for the quarter and nine months ended September 30, 2003, are not necessarily indicative of the results that may be expected for the year ending December 31, 2003. For further information, refer to the consolidated financial statements and footnotes thereto included in the Companys Annual Report on Form 10-K for the year ended December 31, 2002.
Certain prior year amounts have been reclassified to conform to the current year presentation.
| Stock-based Compensation |
HCA applies Accounting Principles Board Opinion No. 25, Accounting for Stock Issued to Employees and related interpretations in accounting for its employee stock benefit plans. Accordingly, no compensation cost has been recognized for HCAs stock options granted under the plans, because the exercise prices for options granted were equal to the quoted market prices on the option grant dates and all option grants were to employees or directors.
HCA determined pro forma net income and earnings per share, as if compensation cost for HCAs employee stock option and stock purchase plans had been determined based upon fair values at the grant
6
| NOTE 1 | INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (continued) |
| Stock-based Compensation (continued) |
dates. These pro forma amounts for the respective quarters and nine months ended September 30, 2003 and 2002 are as follows (dollars in millions, except per share amounts):
| Quarter | Nine Months | ||||||||||||||||
| 2003 | 2002 | 2003 | 2002 | ||||||||||||||
|
Net income:
|
|||||||||||||||||
|
As reported
|
$ | 306 | $ | 200 | $ | 1,015 | $ | 935 | |||||||||
|
Stock-based employee compensation expense
determined under a fair value method, net of income taxes
|
20 | 16 | 73 | 48 | |||||||||||||
|
Pro forma
|
$ | 286 | $ | 184 | $ | 942 | $ | 887 | |||||||||
|
Basic earnings per share:
|
|||||||||||||||||
|
As reported
|
$ | 0.62 | $ | 0.39 | $ | 2.01 | $ | 1.83 | |||||||||
|
Pro forma
|
$ | 0.58 | $ | 0.36 | $ | 1.87 | $ | 1.73 | |||||||||
|
Diluted earnings per share:
| |||||||||||||||||